Statistics
Publications
2
Citations
182
H-Index
2
Active since
2018
Affiliations
Eli Lilly (United States)(Current)
Ryan Sides is an author at Eli Lilly (United States) specializing in migraine pharmacotherapy, clinical pharmacology, and pharmacy.
Publications per year
2018–2018
2
2
A phase 3, long-term, open-label safety study of Galcanezumab in patients with migraine
Angelo Camporeale, David Kudrow, Ryan Sides et al. · BMC Neurology · 2018 · 141 citations · Full text
Virginia L. Stauffer, Ryan Sides, Michel Lantéri‐Minet et al. · Patient Preference and Adherence · 2018 · 41 citations · Full text
1–2 of 2